Cargando…

An eHealth intervention (ManGuard) to reduce cardiovascular disease risk in male taxi drivers: protocol for a feasibility randomised controlled trial

BACKGROUND: Men are at higher risk then women of developing cardiovascular disease (CVD), and male taxi drivers are a particularly high-risk group because of their typically unhealthy behaviours, such as poor eating habits, smoking and sedentary lifestyle. However, only two studies of behavioural in...

Descripción completa

Detalles Bibliográficos
Autores principales: McMahon, James, Thompson, David R., Brazil, Kevin, Ski, Chantal F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472349/
https://www.ncbi.nlm.nih.gov/pubmed/36104740
http://dx.doi.org/10.1186/s40814-022-01163-4
_version_ 1784789286210502656
author McMahon, James
Thompson, David R.
Brazil, Kevin
Ski, Chantal F.
author_facet McMahon, James
Thompson, David R.
Brazil, Kevin
Ski, Chantal F.
author_sort McMahon, James
collection PubMed
description BACKGROUND: Men are at higher risk then women of developing cardiovascular disease (CVD), and male taxi drivers are a particularly high-risk group because of their typically unhealthy behaviours, such as poor eating habits, smoking and sedentary lifestyle. However, only two studies of behavioural interventions targeting taxi drivers have been identified, one of which reported a high attrition rate. Therefore, an eHealth intervention co-designed by taxi drivers may prove more acceptable and effective. The aim of this study is to assess the feasibility an eHealth intervention (ManGuard) to reduce CVD risk in male taxi drivers. METHODS: A randomised wait-list controlled trial will be conducted with a sample of 30 male taxi drivers to establish feasibility, including recruitment, engagement, and retention rates. Program usability and participant satisfaction will be assessed by a survey completed by all participants at 3 months after allocation. Additionally, an in-depth qualitative process evaluation to explore acceptability of the intervention will be conducted with a subset of participants by semi-structured telephone interviews. Preliminary efficacy of ManGuard for improving key CVD-related outcomes will be assessed, including biomarkers (total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, and total/HDL cholesterol ratio), blood pressure, anthropometry (body mass index, body fat percentage, and waist circumference), physical activity (accelerometery, and self-report) and psychosocial status (health-related quality of life, self-efficacy, and social support). Outcomes will be assessed at baseline, 7 weeks, and 3 months after group allocation. The wait-list control group will be offered access to the intervention at the completion of data collection. DISCUSSION: eHealth interventions show potential for promoting behaviour change and reducing CVD risk in men, yet there remains a paucity of robust evidence pertaining to male taxi drivers, classified as a high-risk group. This study uses a randomised controlled trial to assess the feasibility of ManGuard for reducing CVD risk in male taxi drivers. It is envisaged that this study will inform a fully powered trial that will determine the effectiveness of eHealth interventions for this high risk and underserved population. TRIAL REGISTRATION: This trial has been registered prospectively on the ISRCTN registry on 5 January 2022, registration number ISRCTN29693943 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40814-022-01163-4.
format Online
Article
Text
id pubmed-9472349
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-94723492022-09-15 An eHealth intervention (ManGuard) to reduce cardiovascular disease risk in male taxi drivers: protocol for a feasibility randomised controlled trial McMahon, James Thompson, David R. Brazil, Kevin Ski, Chantal F. Pilot Feasibility Stud Study Protocol BACKGROUND: Men are at higher risk then women of developing cardiovascular disease (CVD), and male taxi drivers are a particularly high-risk group because of their typically unhealthy behaviours, such as poor eating habits, smoking and sedentary lifestyle. However, only two studies of behavioural interventions targeting taxi drivers have been identified, one of which reported a high attrition rate. Therefore, an eHealth intervention co-designed by taxi drivers may prove more acceptable and effective. The aim of this study is to assess the feasibility an eHealth intervention (ManGuard) to reduce CVD risk in male taxi drivers. METHODS: A randomised wait-list controlled trial will be conducted with a sample of 30 male taxi drivers to establish feasibility, including recruitment, engagement, and retention rates. Program usability and participant satisfaction will be assessed by a survey completed by all participants at 3 months after allocation. Additionally, an in-depth qualitative process evaluation to explore acceptability of the intervention will be conducted with a subset of participants by semi-structured telephone interviews. Preliminary efficacy of ManGuard for improving key CVD-related outcomes will be assessed, including biomarkers (total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, and total/HDL cholesterol ratio), blood pressure, anthropometry (body mass index, body fat percentage, and waist circumference), physical activity (accelerometery, and self-report) and psychosocial status (health-related quality of life, self-efficacy, and social support). Outcomes will be assessed at baseline, 7 weeks, and 3 months after group allocation. The wait-list control group will be offered access to the intervention at the completion of data collection. DISCUSSION: eHealth interventions show potential for promoting behaviour change and reducing CVD risk in men, yet there remains a paucity of robust evidence pertaining to male taxi drivers, classified as a high-risk group. This study uses a randomised controlled trial to assess the feasibility of ManGuard for reducing CVD risk in male taxi drivers. It is envisaged that this study will inform a fully powered trial that will determine the effectiveness of eHealth interventions for this high risk and underserved population. TRIAL REGISTRATION: This trial has been registered prospectively on the ISRCTN registry on 5 January 2022, registration number ISRCTN29693943 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40814-022-01163-4. BioMed Central 2022-09-14 /pmc/articles/PMC9472349/ /pubmed/36104740 http://dx.doi.org/10.1186/s40814-022-01163-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Study Protocol
McMahon, James
Thompson, David R.
Brazil, Kevin
Ski, Chantal F.
An eHealth intervention (ManGuard) to reduce cardiovascular disease risk in male taxi drivers: protocol for a feasibility randomised controlled trial
title An eHealth intervention (ManGuard) to reduce cardiovascular disease risk in male taxi drivers: protocol for a feasibility randomised controlled trial
title_full An eHealth intervention (ManGuard) to reduce cardiovascular disease risk in male taxi drivers: protocol for a feasibility randomised controlled trial
title_fullStr An eHealth intervention (ManGuard) to reduce cardiovascular disease risk in male taxi drivers: protocol for a feasibility randomised controlled trial
title_full_unstemmed An eHealth intervention (ManGuard) to reduce cardiovascular disease risk in male taxi drivers: protocol for a feasibility randomised controlled trial
title_short An eHealth intervention (ManGuard) to reduce cardiovascular disease risk in male taxi drivers: protocol for a feasibility randomised controlled trial
title_sort ehealth intervention (manguard) to reduce cardiovascular disease risk in male taxi drivers: protocol for a feasibility randomised controlled trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472349/
https://www.ncbi.nlm.nih.gov/pubmed/36104740
http://dx.doi.org/10.1186/s40814-022-01163-4
work_keys_str_mv AT mcmahonjames anehealthinterventionmanguardtoreducecardiovasculardiseaseriskinmaletaxidriversprotocolforafeasibilityrandomisedcontrolledtrial
AT thompsondavidr anehealthinterventionmanguardtoreducecardiovasculardiseaseriskinmaletaxidriversprotocolforafeasibilityrandomisedcontrolledtrial
AT brazilkevin anehealthinterventionmanguardtoreducecardiovasculardiseaseriskinmaletaxidriversprotocolforafeasibilityrandomisedcontrolledtrial
AT skichantalf anehealthinterventionmanguardtoreducecardiovasculardiseaseriskinmaletaxidriversprotocolforafeasibilityrandomisedcontrolledtrial
AT mcmahonjames ehealthinterventionmanguardtoreducecardiovasculardiseaseriskinmaletaxidriversprotocolforafeasibilityrandomisedcontrolledtrial
AT thompsondavidr ehealthinterventionmanguardtoreducecardiovasculardiseaseriskinmaletaxidriversprotocolforafeasibilityrandomisedcontrolledtrial
AT brazilkevin ehealthinterventionmanguardtoreducecardiovasculardiseaseriskinmaletaxidriversprotocolforafeasibilityrandomisedcontrolledtrial
AT skichantalf ehealthinterventionmanguardtoreducecardiovasculardiseaseriskinmaletaxidriversprotocolforafeasibilityrandomisedcontrolledtrial